Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Intra-Cellular Therapies, Inc."
Count: 23
Selected: 0
NCT IDTitle
NCT03249376Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
NCT03489772Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement
NCT04709224Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia
NCT04934124Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers
NCT04959032Lumateperone for the Prevention of Relapse in Patients With Schizophrenia
NCT05061719An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05061706Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT04985942Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT04285515Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder
NCT04779177Safety, Tolerability, and Pharmacokinetics of Lumateperone in Pediatric Patients With Schizophrenia or Schizoaffective Disorder
NCT02817906ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease
NCT02600494Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression
NCT02600507Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
NCT03387215Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure
NCT03257046Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ITI-214 in Parkinson's Disease
NCT02078310Study of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia
NCT02469155A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment
NCT02288845Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia
NCT02282761A Trial to Assess the Antipsychotic Efficacy of ITI-007
NCT01499563Study of a Novel Antipsychotic ITI-007 in Schizophrenia
NCT05356013Caplyta in Borderline Personality Disorder
NCT03817528ITI-007 (Lumateperone Tosylate) for Schizophrenia
NCT01900522Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia